Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Selective Immunosuppressants - Imlifidasa Ii.

Institut klinicke a experimentalni mediciny Czech Republic has Released a tender for Selective Immunosuppressants - Imlifidasa Ii. in Pharmaceuticals. The tender was released on Apr 29, 2025.

Country - Czech Republic

Summary - Selective Immunosuppressants - Imlifidasa Ii.

Deadline - May 27, 2025

GT reference number - 107801911

Product classification - Immunosuppressive agents

Organization Details:

  Address - Czech Republic

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 107801911

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The subject of the public contract is regular supplies of medicinal products for parenteral administrations containing the active substance IMLIFIDASA (ATC Group L04AA41) for the treatment of hospitalized patients in approved indications according to the SPC valid on the date of tenders.local title:: Selektivní imunosupresiva - Imlifidasa II.Contract Type: : Supplylocal description: : Předmětem veřejné zakázky jsou pravidelné dodávky léčivých přípravků pro parenterální podání s obsahem účinné látky imlifidasa (ATC skupiny L04AA41) pro léčbu hospitalizovaných pacientů ve schválených indikacích dle SPC platného ke dni podání nabídek.Net Budget Euro

Gt Ref Id - 107801911

Deadline - May 27, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database